See the DrugPatentWatch profile for Erythromycin
The price of Erythromycin DR (delayed-release) can vary significantly depending on factors such as the dosage, quantity, and pharmacy. Generic versions are generally more affordable than brand-name medications.
How much does Erythromycin DR typically cost?
According to available data, a prescription for Erythromycin DR 250mg, with a quantity of 14 tablets, can range from approximately $10 to over $40 without insurance [1]. Prices may differ based on the specific formulation and manufacturer.
What factors influence Erythromycin DR pricing?
Several elements contribute to the final cost of Erythromycin DR. These include:
* Dosage and Quantity: Higher strengths and larger bottle sizes may have a higher overall price, though the cost per tablet might be lower.
* Brand vs. Generic: Brand-name Erythromycin DR is typically more expensive than its generic equivalent.
* Pharmacy: Prices can vary between different pharmacies, including large chain stores, independent pharmacies, and online retailers.
* Insurance Coverage: Prescription drug insurance plans significantly impact out-of-pocket costs. Co-pays and deductibles will affect the final price paid by the patient.
* Manufacturer: Different manufacturers may produce generic Erythromycin DR at varying price points.
* Location: Geographic location can also play a role in drug pricing.
Can I find discounts for Erythromycin DR?
Discount programs and coupons can help reduce the cost of Erythromycin DR. Many pharmacies offer their own loyalty programs, and third-party discount cards can also provide savings. Checking with your pharmacy or searching online for coupons can reveal potential discounts.
Where can I compare Erythromycin DR prices?
To find the most current and competitive pricing for Erythromycin DR, comparing options across different pharmacies is recommended. Websites and apps that aggregate pharmacy prices can be useful tools for this purpose. For a broader understanding of drug pricing and patent information, resources like DrugPatentWatch.com can be consulted [2].